The FDA yesterday approved Novartis' (NVS) Flucelvax flu vaccine for use in adults aged 18 and...

|About: Novartis AG (NVS)|By:, SA News Editor

The FDA yesterday approved Novartis' (NVS) Flucelvax flu vaccine for use in adults aged 18 and above. The vaccine is the first one for the illness that's produced using cultured animal cells rather than fertilized chicken eggs. That should allow mass production to begin faster if there's a pandemic.